Very true that financial remuneration is almost always involved in the marketing of medical products by medical professionals. I also agree, the truth definitely is reflected in the sales and recurring revenue numbers - I don't doubt the existing iTrack customers will transition over to the Advance. I haven't compared the revenue per customer across the competition, if you have the numbers handy that would be very helpful.
Nova Eye Medical (EYE) Discussion, page-909
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.010(4.76%) |
Mkt cap ! $50.39M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 22.5¢ | 21.0¢ | $84.60K | 389.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 100224 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 23847 | 1 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| EYE (ASX) Chart |